Clinical Trial Detail

NCT ID NCT03050060
Title Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, and Nivolumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

lung non-small cell carcinoma

melanoma

renal carcinoma

Therapies

Nelfinavir + Nivolumab

Age Groups: adult senior

No variant requirements are available.